BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7989462)

  • 1. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema.
    Okuda J; Akamizu T; Sugawa H; Matsuda F; Hua L; Mori T
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1600-4. PubMed ID: 7989462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
    Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema.
    Moriyama K; Okuda J; Saijo M; Hattori Y; Kanamoto N; Hataya Y; Matsuda F; Mori T; Nakao K; Akamizu T
    J Endocrinol Invest; 2003 Nov; 26(11):1076-80. PubMed ID: 15008244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
    Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
    J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variable-regions of immunoglobulin H-chain genes encoding anti-TSH receptor antibodies].
    Matsuda F
    Nihon Rinsho; 1994 Apr; 52(4):1013-7. PubMed ID: 7910858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
    Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
    Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
    J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.
    Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M
    Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease.
    Shin EK; Akamizu T; Matsuda F; Sugawa H; Fujikura J; Mori T; Honjo T
    J Immunol; 1994 Feb; 152(3):1485-92. PubMed ID: 8301147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.
    Chiovato L; Vitti P; Santini F; Lopez G; Mammoli C; Bassi P; Giusti L; Tonacchera M; Fenzi G; Pinchera A
    J Clin Endocrinol Metab; 1990 Jul; 71(1):40-5. PubMed ID: 2164529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity.
    Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myxedema and thyroid function of their neonates.
    Inomata H; Sasaki N; Tamaru K; Ushiku H; Niimi H; Nakajima H
    Endocrinol Jpn; 1986 Jun; 33(3):353-9. PubMed ID: 3019652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease.
    Li H; Akamizu T; Okuda J; Sugawa H; Matsuda F; Tsubata T; Mori T
    Biochem Biophys Res Commun; 1995 Feb; 207(3):985-93. PubMed ID: 7864905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.